- CA$14.76m
- CA$23.43m
- CA$0.47m
Brief: MedX Announces Non-Brokered Private Placement Of Series IV Convertible Loan Notes
Brief: Medx Announces Final Closing Of Non-Brokered Private Placement
Brief: Medx Announces Proposed Non-Brokered Private Placement To Raise Up To $2,500,000 And Stock Option Grants
Brief: Medx Announces Final Closing Of Non-Brokered Private Placement
Brief: Medx Health Announces Initial Closing And Proposed Extension Of Non-Brokered Private Placement Offering, And An Update On Series I Convertible Loan Notes Amendment
Brief: Medx Health Corp. Announces Proposed Extension Of Non-Brokered Private Placement Offering
Brief: MedX Announces Intention To Seek Acceptance For Amendment To Series I Convertible Loan Notes
Brief: Medx Health Corp Announces Conversion Of $2.965 Mln Of Secured Convertible Debentures
Brief: Medx Health Announces Closing Of Non-Brokered Private Placement
Brief: Medx Appoints Stephen Lockyer As CEO
Brief: Medx Health And Pharmachoice Announce Agreement To Launch Medx Teledermatology Screening Platform in Canada
Brief: Medx Health Announces Final Closing Of Secured Convertible Debenture Financing
Brief: Medx Announces Proposed Secured Convertible Debenture Financing
Brief: Medx Announces Closing Of Secured Convertible Debenture Financing
Brief: MedX Announces Proposed Secured Convertible Debenture Financing
Brief: Medx Health Applies For Extension Of Price Protection For Private Placement Convertible Loan Note Financing
Brief: Medx Health Announces Launch Of Its Dermatological Screening Services In Newfoundland And Labrador
Brief: MedX Health Applies For Further Extension Of Price Protection For Private Placement Convertible Loan Note Financing
Brief: MedX Health Applies for Extension of Price Protection for Private Placement Convertible Loan Note Financing